Authors: | Rugo, H. S.; Barry, W. T.; Moreno-Aspitia, A.; Lyss, A.; Huebner, L.; Mayer, E. L.; Naughton, M.; Layman, R. M.; Carey, L. A.; Somer, R. A.; Toppmeyer, D.; Velasco, M.; Perez, E. A.; Hudis, C. A.; Winer, E. |
Abstract Title: | Long-term follow-up of CALGB 40502/NCCTG N063H (Alliance): A randomized phase III trial of weekly paclitaxel (P) compared to weekly nanoparticle albumin bound nab-paclitaxel (NP) or ixabepilone (Ix) +/- bevacizumab as first-line therapy for locally recurrent or metastatic breast cancer (MBC) |
Meeting Title: | 40th Annual San Antonio Breast Cancer Symposium (SABCS 2017) |
Journal Title: | Cancer Research |
Volume: | 78 |
Issue: | 4 Suppl. |
Meeting Dates: | 2017 Dec 5-9 |
Meeting Location: | San Antonio, TX |
ISSN: | 0008-5472 |
Publisher: | American Association for Cancer Research |
Date Published: | 2018-02-01 |
Language: | English |
ACCESSION: | WOS:000425489400020 |
PROVIDER: | wos |
DOI: | 10.1158/1538-7445.SABCS17-GS3-06 |
Notes: | Meeting Abstract: GS3-06 -- Source: Wos |